Corrigendum: C-reactive protein levels could be a prognosis predictor of prostate cancer: A meta-analysis.

Zhou, Kechong; Li, Chao; Chen, Tao; Zhang, Xuejun; Ma, Baoluo

Zhou, Kechong; Li, Chao; Chen, Tao; Zhang, Xuejun; Ma, Baoluo.

Afiliação

Zhou K; Department of Urology, Xiangyang Central Hospital, Affiliated Hospital of Hubei University of Arts and Science, Xiangyang, Hubei, China.
Li C; Department of Orthopedics, Xiangyang Central Hospital, Affiliated Hospital of Hubei University of Arts and Science, Xiangyang, Hubei, China.
Chen T; Department of Urology, Xiangyang Central Hospital, Affiliated Hospital of Hubei University of Arts and Science, Xiangyang, Hubei, China.
Zhang X; Department of Urology, Xiangyang Central Hospital, Affiliated Hospital of Hubei University of Arts and Science, Xiangyang, Hubei, China.
Ma B; Department of Urology, Xiangyang Central Hospital, Affiliated Hospital of Hubei University of Arts and Science, Xiangyang, Hubei, China.

Front Endocrinol (Lausanne) ; 14: 1176102, 2023.

Article em En | MEDLINE | ID: mdl-37082133

Palavras-chave

C-reactive protein; crp; meta-analysis; prognosis; prostate cancer; survival

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Bases de dados: MEDLINE Tipo de estudo: Prognostic_studies / Risk_factors_studies / Systematic_reviews Idioma: En Revista: Front Endocrinol (Lausanne) Ano de publicação: 2023 Tipo de documento: Article País de afiliação: China

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google